Sorafenib

met proto-oncogene ; Mus musculus







4 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30881018 ARQ-197 enhances the antitumor effect of sorafenib in hepatocellular carcinoma cells via decelerating its intracellular clearance. 2019 1
2 29881824 Inhibition of insulin-like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival. 2018 Jun 1
3 28164434 Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells. 2017 Mar 2
4 27716356 Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro. 2016 Sep 30 1